Nachrichten zur Eli Lilly & Co. Aktie

Is Ozempic maker Novo Nordisk losing to Eli Lilly in the obesity wars?

Eli Lilly and Co (NYSE:LLY) is tightening its grip on the obesity drug market, with its injectable treatment Zepbound gaining…

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Its hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug…

Zepbound copycats remain online despite FDA ban

Copycat versions of Eli Lillys diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. Theyre…

J&J touts $55B in planned US investments over 4 years, including 3 new manufacturing sites

Johnson & Johnson says it will s | Johnson & Johnson will invest $55 billion in the U.S. over the…

Eli Lilly’s diabetes and weight-loss drug Mounjaro debuts in India By Investing.com

Eli Lilly’s diabetes and weight-loss drug Mounjaro debuts in India…

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market By Reuters

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market…

Lillys weight-loss drug launch in India to energize rivals eyeing mega market

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20…

Eli Lilly launches weight-loss drug Mounjaro in India after drug regulator approval

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from countrys drug regulator, it…

Eli Lilly (LLY) Stock Moves -0.27%: What You Should Know

Eli Lilly (LLY) concluded the recent trading session at $822.51, signifying a -0.27% move from its prior days close.…

Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors

The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024. The Nasdaq…

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? Thats understandable. Fear, uncertainty, and doubt have become the norm in…

An Ozempic successor falls short, Eli Lillys GLP-1 pill, and senators grill RFK: Pharma news roundup

Plus, Eli Lillys CEO got a pay raise, and Viking Therapeutics gets closer to bringing its Ozempic competitor to market…

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know

In the most recent trading session, Eli Lilly (LLY) closed at $822.27, indicating a -0.22% shift from the previous trading…

Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would…

Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and its an element you…

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Though Eli Lilly stock looks quite expensive, we suggest investors hold on to it as it still has robust growth…

Why Eli Lilly Stock Flopped Today

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Mondays…

The Reality of Trumps Tariffs

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss: The impacts of tariffs on investors and companies. If…

The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They…

This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?

Its not too often that pharmaceutical drugs become household names, but thats happening with medicines in the weight loss market.…

3 Magnificent Growth Stocks to Buy in March

Its often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We…

Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know

Eli Lilly (LLY) closed the most recent trading day at $912.76, moving -1.82% from the previous trading session.…

Two telehealth firms turn to branded Zepbound as restrictions loom on copies

Telehealth firms Teladoc and LifeMD said they signed an agreement with Eli Lillys pharmacy partner to offer patients the weight-loss drug, Zepbound.…

Hims & Hers falls after US judge denies injunction on Zepbound copies

** Shares of telehealth firm Hims & Hers NYSE:HIMS fall 9% to $37.2 premarket ** A U.S. federal judge has…

Hims & Hers stock down as Zepbound motion denied (LLY:NYSE)

Hims & Hers (HIMS) stock falls 8% as court denies injunction on FDA ruling for Eli Lillys (LLY) Zepbound shortage.…

3 Monster Stocks to Hold for the Next 10 Years

Whats a monster stock? In my book, its a company thats built a long track record of earnings growth thanks…

Novo Nordisk goes direct to consumer with Wegovy. What it means for obesity rival Eli Lilly

Shares of Eli Lilly rose Wednesday despite its rivals announcement.…

Amgen starts two critical late-stage trials for weight loss drug MariTide

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli…

Nvidia, Apple, and Eli Lilly: Manufacturing the Future

The great buildout for AI and GLP-1 drugs continues.…

Lillys Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe

The CHMP gives a positive opinion to Eli Lillys Jaypirca in patients with relapsed or refractory CLL in a post-BTK…

Where Will Eli Lilly Be in 5 Years?

Its hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years.…

Eli Lillys big investment, cheaper Zepbound, and Hims & Hers options: Pharma news roundup

Plus, Modernas bird flu contract with the U.S. is being evaluated…

Eli Lillys big investment, cheaper Zepbound, and Hims & Hers options: Pharma news roundup

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant…

Eli Lilly investing $27B more in US manufacturing

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest…

Prediction: Novo Nordisk Will Soar Over the Next 5 Years. Heres 1 Reason Why.

After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO)…

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing…

Eli Lilly CEO on $27 billion investment in U.S. manufacturing expansion

CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join Squawk on the Street to discuss the companys U.S. manufacturing…

Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs

Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker…

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional…

Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing…

Novo Nordisk should withstand competition from new Eli Lilly diabetes drug, says Wall Street bank

JP Morgan is optimistic about Novo Nordisk (NYSE:NVO) despite competition from Eli Lilly’s new drug, orforglipron. Its analysts reckon Novo will…

Eli Lilly announces $27B investment in US drug manufacturing

Eli Lilly and Co (NYSE:LLY) plans to invest at least $27 billion in four new US manufacturing facilities, the company…

Eli Lilly Latest US Company to Commit to Domestic Investments

Eli Lilly plans to invest at least $27 billion to build four new manufacturing sites in the U.S., a week…

Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company

The Investor Relations website contains information about Eli Lilly and Companys business for stockholders, potential investors, and financial analysts.…

Why Eli Lilly Stock Popped Today

Eli Lilly (NYSE: LLY) stock defied todays market downturn, rising 2.6% through 11:15 a.m. ET on the back of two…

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.…

Stocks making the biggest moves premarket: Eli Lilly, Keurig Dr Pepper, Home Depot, Chegg and more

These are the stocks posting the largest moves in early trading.…

Hims & Hers stock collapses on halt of weight-loss drug sales

Hims & Hers (HIMS) stock collapsed after confirming it will stop selling compounded weight-loss drugs. Despite strong revenue growth, analysts…

Eli Lilly introduces new doses of weight loss drug Zepbound at discounted prices

Eli Lilly and Co (NYSE:LLY) has announced a reduction in the price of its weight-loss medication Zepbound for patients who pay…

Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in…